XML 20 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows used in operating activities:    
Net loss $ (119) $ (10,802)
Adjustments to reconcile net loss to net cash used in operating activities (see Schedule A) (3,444) 12,989
Net cash provided by (used in) operating activities - continuing operations (3,563) 2,187
Net cash used in operating activities - discontinued operations (956) (3,168)
Net cash used in operating activities (4,519) (981)
Cash flows provided by (used in) investing activities:    
Acquisitions of property and equipment (33) (159)
Restricted deposits (75) (5,071)
Release of restricted deposits 868 1,065
Proceeds from the sale of interests in DSIT, net of transaction costs and cash divested 3,947
Escrow deposits (579) (100)
Release of escrow deposits 100
Amounts funded for severance assets (69) (164)
Net cash provided by (used in) investing activities - continuing operations 4,159 (4,429)
Net cash provided by investing activities - discontinued operations 900 720
Net cash provided by (used in) investing activities 5,059 (3,709)
Cash flows provided by (used in) financing activities:    
Short-term bank credit, net 1,156 (590)
Proceeds from Leap Tide transaction 2,000
Repayment of Leap Tide loan (2,000)
Proceeds from director loans 425
Repayment of director loans (275)
Proceeds from outside investment in OmniMetrix 1,000
Proceeds from the exercise of DSIT options 391
Repayments of long-term debt (43) (129)
Net cash provided by (used in) financing activities - continuing operations (346) 2,281
Net cash used in financing activities - discontinued operations (138) (2,182)
Net cash provided by (used in) financing activities (484) 99
Effect of exchange rate changes on cash and cash equivalents - continuing operations (5) 50
Effect of exchange rate changes on cash and cash equivalents - discontinued operations 18 (160)
Net increase (decrease) in cash and cash equivalents 69 (4,701)
Cash and cash equivalents at beginning of year - discontinued operations 48 192
Cash and cash equivalents at beginning of year - continuing operations 124 4,681
Cash and cash equivalents at end of year - discontinued operations 19 48
Cash and cash equivalents at end of year - continuing operations 222 124
Cash paid during the year for:    
Interest 323 223
Income taxes, net of refunds 4 (26)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Loss from discontinued operations 286 4,695
Depreciation and amortization 146 314
Accretion of Leap Tide discount 100 62
Common stock issued for Leap Tide interest accrued 281
Conversion to common stock of interest due to director 15
Gain on sale of interests in DSIT, net of income taxes and transaction costs (3,543)
Share of income in DSIT (268)
Change in deferred taxes 18 258
Inventory write-down 9 22
Increase in liability for accrued severance 67 245
Stock-based compensation 89 661
Deconsolidation of USSI 401
Other 35 (2)
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 218 (2,235)
Decrease (increase) in unbilled revenue (949) 4,041
Increase in inventory (2) (19)
Decrease (increase) in other current assets and other assets (170) 55
Increase (decrease) in deferred revenue (863) 3,640
Increase in accounts payable, accrued payroll, payroll taxes and social benefits, other current and non-current liabilities 1,087 851
Adjustments to reconcile net loss to net cash provided by (used in) operating activities, total (3,444) 12,989
Non-cash investing and financing activities:    
Adjustment of paid-in-capital and non-controlling interest from the deconsolidation of DSIT 242  
Conversion of director loan and interest to common stock 115  
Investment in DSIT from deconsolidation 5,390  
Liability for insufficient number of authorized shares in capital raise (50)
Value of Initial Shares (discount) in Leap Tide transaction   162
Adjustment of paid-in-capital and non-controlling interest from the deconsolidation of USSI   541
Accrued preferred dividends to outside investor in OmniMetrix subsequently converted to long-term loan $ 100 $ 15